TickerFactsScreenerDevelopers

Emergent BioSolutions Inc. (EBS) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2009: $29.87M2010: $98.02M2011: $12.19M2012: $39.64M2013: $96.97M2014: $112.32M2015: $42.52M2016: $54.60M2017: $208.10M2018: $41.80M2019: $188.00M2020: $536.90M2021: $320.20M2022: -$34.10M2023: -$206.30M2024: $58.70M2025: $170.60M$170.60M
2009Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$170.60M+190.6%
2024$58.70M+128.5%
2023-$206.30M-505.0%
2022-$34.10M-110.6%
2021$320.20M-40.4%
2020$536.90M+185.6%
2019$188.00M+349.8%
2018$41.80M-79.9%
2017$208.10M+281.1%
2016$54.60M+28.4%
2015$42.52M-62.1%
2014$112.32M+15.8%
2013$96.97M+144.6%
2012$39.64M+225.3%
2011$12.19M-87.6%
2010$98.02M+228.2%
2009$29.87M—